Table 2 Clinicopathologic features of the LUAD validation group
Characteristic | Varl | Freq |
|---|---|---|
Age | Range | 26–76 |
Median | 60 | |
Gender | Male | 17 (33.33) |
Female | 34 (66.67) | |
Smoke | Yes | 11 (21.56) |
No | 40 (78.43) | |
Tstage | T1 | 10 (19.60) |
T2 | 28 (54.90) | |
T3 | 9 (17.64) | |
T4 | 4 (7.84) | |
Nstage | N0 | 29 (56.86) |
N1 | 6 (11.76) | |
N2 | 16 (31.37) | |
ImmuneSubtype | C1 | 0 (0) |
C2 | 34 (66.67) | |
C3 | 13 (25.49) | |
C4 | 3 (5.88) | |
C6 | 1 (1.96) |